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Cerebellar granule cells, differentiated in vitro, were parallelly fed with [Sph-‘H]GMl and [stearoyl-‘%]GMl, under identical conditions (low6 M 
ganglioside; pulse, from 14 h; chase, up to 24 h after 4 h pulse) and the salvage pathways of sphingosine and stearic acid were investigated. It
was observed that both sphingosine and stearic acid, liberated during the intralysosomal degradation of ganglioside, are metabolically recycled, 
along distinct pathways. Sphingosine is used for the biosynthesis of a number of sphingolipids, particularly ceramide, glucosyl-ceramide, gangli- 
osides and sphingomyelin; stearic acid is utilized for the biosynthesis of sphingolipids, and to a greater extent, glycero-phospholipids, especially 
those endogenously richer in stearic acid (phosphatidyl-ethanolamine and phosphatidyl-choline). No evidence was provided for a salvage pathway 
for ceramide. 
Cerebellar granule cell; Ganglioside; Sphingosine; Fatty acid; Metabolic salvage pathway; Phospholipid 
1. INTRODUCTION 
The composition of the cell plasma membrane is 
maintained constant through a rapid process where the 
individual components are continuously internalized 
and brought back to the surface, a portion of them 
being degraded and substituted by newly synthesized 
molecules. Gangliosides, characteristic omponents of 
the plasma membranes of most vertebrate cells, appear 
to participate in this flow process [2]. They are internal- 
ized by endocytosis [3] and submitted to degradation in 
the lysosomes, with formation of catabolic fragments 
that are partially re-utilized for biosynthetic purposes in 
the endoplasmic reticulum and Golgi apparatus (‘sal- 
vage pathways’) [4]. By the use of gangliosides, radiola- 
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beled in different portions of the molecule and adminis- 
tered to animals or cultured cells, it was demonstrated 
that different monosaccharides derived from gangli- 
oside (NeuAc, Gal, GalNAc) undergo salvage pathways 
[5-81. In rat liver it was also shown that some catabolic 
fragments from the lipid moiety of gangliosides are 
metabolically recycled, particularly, glucosyl-ceramide 
for the biosynthesis of gangliosides, sphingosine for that 
of sphingomyelin, and fatty acid for that of phospholip- 
ids [9]. 
In the present work we investigated the salvage path- 
ways occurring in cultivated neurons for the sphingo- 
sine and fatty acid moieties of gangliosides. To this 
purpose cerebellar granule cells differentiated in culture 
were fed with ganglioside GMl, radiolabeled at the level 
of the sphingosine ([Sph-3H]GM1) or fatty acid ([stea- 
royl-‘4C]GM1) moiety, and the formation of radiola- 
beled metabolites was followed. We observed that the 
salvage pathways for sphingosine and fatty acid are 
distinct. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Commercial chemicals were of the highest available grade; solvents 
were redistilled before use. Basal modified Eagle’s medium (BME) and 
FCS (heat-inactivated before use) were from Flow Laboratories (Irv- 
ine, UK). Poly-L-lysine, 1-a-o-arabinofuranosylcitosine, N uAc, gen- 
tamycin, crystalline bovine serum albumin, standard phospholipids 
Published by Elsevier Science Publishers B. V. 257 
Volume 322, number 3 FEBS LETTERS May 1993 
(PE, PPE, PC, PPC, PI, PS, SM) and phosphorus standard solution 
were from Sigma Chemical Co. (St. Louis, MO, USA); standard fatty 
acid methyl esters from Supelco (Bellefonte); [‘H]NaBH, (6.5 Ci/ 
mmol) and [l-‘4C]stearic acid (55 mCi/mmol) from Amersham Inter- 
national (Amersham, Bucks, UK). 
Ganglioside GMl, obtained as previously described [lo], was iso- 
topically radiolabeled at the level of (a) C-3 of the long chain base 
([Sph-‘H]GMl) [ll], the molecular species containing erythro-C18- 
sphingosine being separated [12] and used; or (b) C-l of the stearic acid 
([stearoyl-‘4C]GM1) [13]. The specific radioactivity was 1.15 and 0.055 
Ci/mmol respectively, the radiochemical purity being better than 99% 
in both cases. Standard [‘Hjgangliosides, [‘H]lactosyl-ceramide, 
[3H]glucosyl-ceramide, [‘Hlsphingomyelin, [3H]ceramide and 
[3H]sphingosine were obtained as previously reported [14]. 
2.2. Cell cultures 
Granule cells were prepared and cultured as previously described 
[15]. Treatment with radiolabelled gangliosides was carried out on day 
8 in culture, when cells were fully differentiated. Dishes were washed 
twice with temperature-conditioned BME without FCS and incubated 
for a given period of time (pulse) in the same medium (2 ml/dish) 
containing 10e6 M [Sph-3H]GM1 or [stearoyl-‘4C]GM1, carrying 1.15 
~Ci/ml and 0.055 pCi/ml of radioactivity, respectively. The medium 
was then removed and the cells were washed (10 min treatment for 
three times) with BME containing 10% FCS. After different periods 
of incubation (chase) in the same medium, cells were rinsed twice with 
phosphate buffered solution, scraped off the plates and lyophilised. 
2.3. Lipid extraction andpuriJcation 
Total lipids were extracted and partitioned as previously described 
[14]. The individual [‘HIlipids contained in the aqueous (gangliosides) 
and organic (non-ganglioside lipids) phases were separated by HPTLC 
and quantified (see below). The recognition and identification of indi- 
vidual gangliosides, neutral glycolipids, sphingomyelin and ceramide 
was achieved as previously described [14]. Glycerophospholipids were 
separated by HPTLC [16,17] and identified by comparison with au- 
thentic reference standards. 
2.4. HPTLC procedures 
The separation of the different lipids was performed by one-dimen- 
sional HPTLC, usingchloroform/methanol/0.2% CaCl, (50:42:11, v/v) 
for gangliosides, and chloroform/methanol/water (55:20:3, v/v) for 
neutral glycolipids, sphingomyelin, ceramide and sphingosine. Indi- 
vidual phospholipids were separated by two-dimensional HPTLC, 
with intermediate xposure to 12 N HCl fumes [17], using chloroform/ 
methanol/acetic acid/water (30:20:2: 1,v/v) and chloroform/methanol/ 
acetone/acetic acid/water (10:2:4:2:1, v/v) for the first and the second 
run, respectively. After HPTLC, the plates were sprayed with a p- 
dimethylaminobenzaldehyde reagent [18] for ganglioside detection, 
with a diphenylamine reagent [19] for neutral glycolipid detection or 
with a molybdate reagent for phospholipid detection [20]. Plates were 
then densitometrically scanned with a Camag TLC densitometer, con- 
nected to an IBM personal computer, equipped with data analysis 
software. Alternatively, the plates were submitted to autoradiography 
(Digital Autoradiograph, Berthold, Germany). 
2.5. Calorimetric method 
Gangliosides were determined, as bound NeuAc [21], using NeuAc 
as standard; total phospholipids after perchloric acid digestion, ac- 
cording to the method of Bartlett [22], as modified by Dodge and 
Phillips [23]; proteins [24] using bovine serum albumin as the standard. 
2.6. Fatty acid analysis 
Fatty acid analysis was performed on PE and PC, by far the most 
abundant glycerophospholipids of cultured cerebellar granule cells 
(see section 3). To this purpose phospholipids were separated by two- 
dimensional HPTLC (see above) and the spots corresponding to PE 
and PC were scraped off and eluted from the gel by three washes with 
2 ml each of chloroform/methanol (2: 1, v/v). Each phospholipid was 
then hydrolyzed with 0.5 N anhydrous methanolic HCl at 80°C over- 
night in a sealed tube. Fatty acid methyl esters were extracted into 
n-hexane and submitted to GLC as previously described [25]. 
2.7. Determination of radioactivity 
Radioactivity was determined by liquid scintillation counting, 
fluorography or radiochromatoscanning (Digital Autoradiograph, 
Berthold, Germany). Since the two administered gangliosides had 
different specific radioactivity, and in order to facilitate comparative 
evaluations, all data of radioactivity determinations were expressed as 
pmol of radioactive compound/mg protein. 
3. RESULTS AND DISCUSSION 
Previous investigations [6,8,14,16] showed that cere- 
bellar granule cells in culture are able to take up and 
internalize exogenous ganglioside GM1 and to submit 
it to metabolic processing. This process consisted of: (a) 
degradation, with formation of GM2, GM3, lactosyl- 
ceramide, glucosyl-ceramide, ceramide and single com- 
ponents like monosaccharides and sphingosine; (b) for- 
mation of anabolic products originated by either recy- 
cling of catabolic fragment(s) - salvage pathways - 
(GDla, GDl b, GTI b, 0-Ac-GTlb, sphingomyelin, 
etc.) and direct glycosylation of internalized GM1 
(GDla). Both degradative and salvage pathways were 
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Fig. 1. Incorporation of radioactivity into different sphingolipids after 
different pulse times with 10e6 M [Sph-3H]GMl and [stearoyl- 
?Z]GMl in cerebellar granule cells differentiated in culture. Data are 
the mean of three experiments and are expressed as pmol/mg protein. 
S.D. never exceeded 15% of the mean. 
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Fig. 2. Incorporation of radioactivity into sphingolipid metabolites at 
different chase times after four hour pulse with lO-6 M [Sph-3H]GMl 
and [stearoyl-‘4C]GM1 in cerebellar granule cells differentiated in 
culture. Data are the mean of three experiments and are expressed as 
pmol/mg protein. SD. never exceeded 15% of the mean. 
completely stopped by blockage of the lysosomal func- 
tion, indicating the central role of lysosomes in the proc- 
esses [8]. 
With the present work the salvage pathways of the 
lipid components of GMl, sphingosine and fatty acid, 
were explored. To this purpose cerebellar granule cells 
differentiated in culture were parallelly fed with [Sph- 
3H]GM 1 and [stearoyl-r4C]GM 1, under identical condi- 
tions (10m6 M ganglioside; pulse: 14 h; chase, up to 24 
h after 4 h pulse). At all the investigated times the 
amounts of cell associated GMl, and formed labeled 
metabolites, were very similar, regardless of the labeling 
position of administered GMl. 
Out of the radiolabeled molecules produced from ex- 
ogenous GM 1 in the pulse and pulse-chase xperiments, 
some (mainly sphingolipids) were common to both labe- 
lings, and others were detected only with [stearoyl- 
14C]GM1 (glycero-phospholipids) or with [Sph- 
3H]GM1 (sphingosine). With reference to metabolites 
that are common to the two differently labeled gangli- 
osides (Figs. 1 and 2), the amounts of GM2, GM3 and 
lactosyl-ceramide were practically identical in the two 
cases, under both pulse and chase conditions. This indi- 
cates that these metabolites are products of the sequen- 
tial hydrolysis of GMl, as expected. In the case of glu- 
cosyl-ceramide and ceramide their amounts were simi- 
lar only until 2 h of pulse (Fig. 1); for longer incubation 
times a much higher formation was obtained with the 
sphingosine than the stearoyl label (Figs. 1 and 2). Pre- 
sumably, until 2 h of incubation degradation is the main 
process, salvage pathways of catabolic fragments (espe- 
cially sphingosine) becoming predominant thereafter. 
Other metabolites of sphingolipid nature (gangliosides 
GDla, GDlb, 0-Ac-GTlb, GTlb and sphingomyelin) 
underwent a progressive increase during the pulse and 
chase periods. However, at all investigated times, they 
were in much higher amounts after [Sph-3H]- than [stea- 
royl-14C]GM1 administration (Figs. 1 and 2). All this 
means that in cultured cerebellar granule cells sphingo- 
sine and stearic acid, and not a bigger fragment (like 
ceramide) liberated from the degradation of GM 1, are 
re-utilized for the biosynthesis of sphingolipids. Moreo- 
ver, they are metabolically recycled in different propor- 
tion, presumably reflecting the difference in the corre- 
sponding endogenous pools. 
The salvage pathway of sphingosine to sphingomye- 
lin biosynthesis was already reported to occur in other 
cultured cells and tissues [9,26]. On the contrary, the 
evidence that free sphingosine is re-cycled to gangli- 
osides contrasts with data obtained on rat liver [9], 
showing glucosyl-ceramide as the major lipid fragment 
reused for ganglioside biosynthesis. This means that 
metabolic salvage processes imply different metabolites 
and follow different trends in different cells or tissues. 
After [stearoyl-14C]GM1 administration, under both 
pulse and chase conditions, radioactivity was incorpo- 
rated also into glycero-phospholipids, namely PE, PC, 
PI and PS (Fig. 3). Although PC is the main endogenous 
phospholipid of differentiated granule cells, and in de- 
veloping rat cerebellum [27] accounting for more than 
50% of total phospholipids (Fig. 4A and B), PE was the 
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Fig. 3. Incorporation of radioactivity into different glycerophospho- 
lipids at different pulse times, and chase times after four hours pulse, 
with 1O-6 M [stearoyl-‘T]GMl in cerebellar granule cells differen- 
tiated in culture. Data are the mean of three experiments and are 
expressed as pmol/mg protein. S.D. never exceeded 15% of the mean. 
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Fig. 4. Phospholipid content and composition (A and B) and fatty acid 
% composition of PE (C) and PC (D) in cerebellar granule cells differ- 
entiated in culture. Data are expressed as nmol of phospholipid/mg 
protein (A), percent of total phospholipids (B) and percent of main 
fatty acids in PE (C) and PC (D). Data are the mean of four different 
determinations, SD. never exceeding 10% of the mean. 
glycero-phospholipid with the highest radioactivity in- 
corporation. It should, however, be noted that stearic 
acid accounted for 70% of the total fatty acids in PE, 
and only for 9.7% in PC, where the most abundant fatty 
acid (55.6%) was palmitic acid (Figs. 4C and D). Thus 
the metabolic re-utilization of stearic acid, formed from 
ganglioside degradation, seems to reflect the distribu- 
tion of stearic acid within the phospholipids present in 
cerebellar granule cells. Notwithstanding plasmalogens 
(especially PPE) are present in cerebellar granule cells 
(Fig. 4B), no measurable radioactivity was found in 
PPE and PPC. This finding is expected since long-chain 
alcohol is the substrate in the synthesis of ether-linked 
glycero-phospholipids [28]. Remarkably, after [stea- 
royl-14C]GM1 administration the amount of label in- 
corporated into glycero-phospholipids was appreciably 
higher than that incorporated into sphingolipids. 
Concluding, in cerebellar granule cells differentiated 
in culture salvage pathways are operating that metabol- 
ically re-cycle sphingosine and fatty acid, liberated dur- 
ing the degradation of ganglioside. Sphingosine appears 
to be used for the biosynthesis of a number of sphingo- 
lipids, including ceramide, glucosyl-ceramide, gangli- 
osides and sphingomyelin; stearic acid is utilized for the 
biosynthesis of both sphingolipids and, at a greater ex- 
tent, glycero-phospholipids. Since in the experimental 
protocol used sphingosine and stearic acid are formed 
in the lysosomes, whereas their use for biosynthetic pur- 
poses occurs in the endoplasmic reticulum and Golgi 
apparatus, exit of both compounds from the lysosomal 
compartment has to be postulated. It is not known 
whether this process is a protein mediated one as in the 
case of some monosaccharides (GalNAc, NeuAc) [29], 
that are produced in the lysosomes during ganglioside 
degradation. Such a process could be of crucial impor- 
tance also in view of the suggested involvement of 
sphingosine as a metabolic bioregulator [30,31]. 
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